The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

Marea’s Phase IIa study enrolled patients with hypertriglyceridemia—too much fat in the blood. The latest results showed the ...

Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...

Azafaros B.V. today announced that its lead asset, nizubaglustat, has been granted orphan drug designation from regulatory authorities in both the United States and the European Union for the ...

Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.

Learn about Arbutus's promising Hepatitis B treatments, strong financial position, and projections for the global market.